Paper36770760
eEF2K Inhibitor Design: The Progression of Exemplary Structure-Based Drug Design.
Klupt KA and 1 other. Molecules, 2023. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. eEF2K Inhibitor Design: The Progression of Exemplary Structure-Based Drug Design. Papers, record 36770760. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36770760
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Signal Transduction | Major topic |
| Neoplasms | Major topic |
| Rats | |
| Animals | |
| Phosphorylation | |
| Protein Processing, Post-Translational | |
| Drug Design | |
| Elongation Factor 2 Kinase |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| RGPIN-2018-04427 | Natural Sciences and Engineering Research Council of Canada | RGPIN201804 | PubMed |
Source NIH RePORTER
References78
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9115238 | Identification of a protein kinase from Dictyostelium with homology to the novel catalytic domain of myosin heavy chain kinase A. | J Biol Chem | 1997 | https://conductscience.org/library/papers/9115238 | PubMed |
| 2 | 27818922 | A high-throughput screening assay for eukaryotic elongation factor 2 kinase inhibitors. | Acta Pharm Sin B | 2016 | https://conductscience.org/library/papers/27818922 | PubMed |
| 3 | 21624888 | SwissDock, a protein-small molecule docking web service based on EADock DSS. | Nucleic Acids Res | 2011 | https://conductscience.org/library/papers/21624888 | PubMed |
| 4 | 33890716 | Structural dynamics of the complex of calmodulin with a minimal functional construct of eukaryotic elongation factor 2 kinase and the role of Thr348 autophosphorylation. | Protein Sci | 2021 | https://conductscience.org/library/papers/33890716 | PubMed |
| 5 | 21378847 | The rise of fragment-based drug discovery. | Nat Chem | 2009 | https://conductscience.org/library/papers/21378847 | PubMed |
| 6 | 8307162 | Elongation factor-2 kinase: effective inhibition by the novel protein kinase inhibitor rottlerin and relative insensitivity towards staurosporine. | FEBS Lett | 1994 | https://conductscience.org/library/papers/8307162 | PubMed |
| 7 | 34561912 | Target highlights in CASP14: Analysis of models by structure providers. | Proteins | 2021 | https://conductscience.org/library/papers/34561912 | PubMed |
| 8 | 21677641 | NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. | Nature | 2011 | https://conductscience.org/library/papers/21677641 | PubMed |
| 9 | 30678155 | Approaches to the Structure-Based Design of Antivirulence Drugs: Therapeutics for the Post-Antibiotic Era. | Molecules | 2019 | https://conductscience.org/library/papers/30678155 | PubMed |
| 10 | 25224652 | Reversible covalent inhibition of eEF-2K by carbonitriles. | Chembiochem | 2014 | https://conductscience.org/library/papers/25224652 | PubMed |
| 11 | 14583488 | Identification and characterization of an inhibitor of eukaryotic elongation factor 2 kinase against human cancer cell lines. | Cancer Res | 2003 | https://conductscience.org/library/papers/14583488 | PubMed |
| 12 | 11389851 | Crystal structure of the atypical protein kinase domain of a TRP channel with phosphotransferase activity. | Mol Cell | 2001 | https://conductscience.org/library/papers/11389851 | PubMed |
| 13 | 26009171 | Regulation and roles of elongation factor 2 kinase. | Biochem Soc Trans | 2015 | https://conductscience.org/library/papers/26009171 | PubMed |
| 14 | 24732796 | A conserved loop in the catalytic domain of eukaryotic elongation factor 2 kinase plays a key role in its substrate specificity. | Mol Cell Biol | 2014 | https://conductscience.org/library/papers/24732796 | PubMed |
| 15 | 22329831 | Calcium/calmodulin stimulates the autophosphorylation of elongation factor 2 kinase on Thr-348 and Ser-500 to regulate its activity and calcium dependence. | Biochemistry | 2012 | https://conductscience.org/library/papers/22329831 | PubMed |
| 16 | 30268477 | Elongation factor-2 kinase (eEF-2K) expression is associated with poor patient survival and promotes proliferation, invasion and tumor growth of lung cancer. | Lung Cancer | 2018 | https://conductscience.org/library/papers/30268477 | PubMed |
| 17 | 26260792 | Characterization of the Catalytic and Nucleotide Binding Properties of the α-Kinase Domain of Dictyostelium Myosin-II Heavy Chain Kinase A. | J Biol Chem | 2015 | https://conductscience.org/library/papers/26260792 | PubMed |
| 18 | 30187647 | Homology modeling in drug discovery: Overview, current applications, and future perspectives. | Chem Biol Drug Des | 2019 | https://conductscience.org/library/papers/30187647 | PubMed |
| 19 | 34293799 | Highly accurate protein structure prediction for the human proteome. | Nature | 2021 | https://conductscience.org/library/papers/34293799 | PubMed |
| 20 | 18675813 | The alpha-kinases TRPM6 and TRPM7, but not eEF-2 kinase, phosphorylate the assembly domain of myosin IIA, IIB and IIC. | FEBS Lett | 2008 | https://conductscience.org/library/papers/18675813 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42351693 | Synaptic Plasticity-Intrinsic Excitability and Antidepressant Discovery. | Biomedicines | 2026 | https://conductscience.org/library/papers/42351693 | PubMed |
| 39180059 | Reduction of eEF2 kinase alleviates the learning and memory impairment caused by acrylamide. | Cell Biosci | 2024 | https://conductscience.org/library/papers/39180059 | PubMed |
| 39092736 | Machine Learning Meets Physics-based Modeling: A Mass-spring System to Predict Protein-ligand Binding Affinity. | Curr Med Chem | 2025 | https://conductscience.org/library/papers/39092736 | PubMed |
| 37172726 | Structure of the complex between calmodulin and a functional construct of eukaryotic elongation factor 2 kinase bound to an ATP-competitive inhibitor. | J Biol Chem | 2023 | https://conductscience.org/library/papers/37172726 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALPK1 | 80216 | PubTator's text mining | https://conductscience.org/library/genes/80216 | NCBI Gene |
| ALPK3 | 57538 | PubTator's text mining | https://conductscience.org/library/genes/57538 | NCBI Gene |
| EEF2 | 1938 | PubTator's text mining | https://conductscience.org/library/genes/1938 | NCBI Gene |
| EEF2K | 29904 | PubTator's text mining | https://conductscience.org/library/genes/29904 | NCBI Gene |
| KIR2DL4 | 3805 | PubTator's text mining | https://conductscience.org/library/genes/3805 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36770760
GET https://conductscience.org/api/papers/v1/36770760/references?page=2